Yu Dong

Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors

Yikai Luo, Yu Xia, Dan Liu et al. · Cell · 2024 · 69 citations · Full text

TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy

Nuoyan Zheng, Kaifeng Xie, Hongjian Ye et al. · JCI Insight · 2020 · 54 citations · Full text

Glomerular Disease, T-regulatory Cell, Renal Pathology +25

<p>Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease</p>

Qing Ya Wang, Yuan Li, Ze Yin Liang et al. · Cancer Management and Research · 2019 · 23 citations · Full text

HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients

Lei Li, Yu Gu, Mengpei Zhang et al. · npj Precision Oncology · 2023 · 21 citations · Full text

The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy

Haoran Jiang, Yu Dong, Wei Zong et al. · BMC Women s Health · 2022 · 12 citations · Full text